Akzo Nobel Settles Antitrust Litigation Over Remeron Patents For $59.8M
Dutch conglomerate Akzo Nobel and its subsidiary Organon USA have agreed to settle litigation over its patents for antidepressant Remeron for $59.8 million, but the company still faces risks of class-action...To view the full article, register now.
Already a subscriber? Click here to view full article